Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

Myasthenia gravis market to reach $13.0bn across 7MM by 2034

Aug 28, 2026, 3:36 PM

Read Full Article → Myasthenia gravis market to reach $13.0bn across 7MM by 2034

Myasthenia gravis market to reach $13.0bn across 7MM by 2034

Translate article text

Choose a language and wait for the translated text.

The myasthenia gravis (MG) market across the 7MM is poised to grow at a CAGR of 11.1% from $4.5bn in 2024 to $13.0bn in 2034.

Myasthenia gravis market to reach $13.0bn across 7MM by 2034 | PharmaVoice